Sign in to view content

Higher-Order Optical Coherence Tomography Fluid Burden Assessment: Analysis From the OSPREY Trial

Justis P. Ehlers, MD, FASRS

Video
Published 2019

Justis Ehlers, MD

AMD Neovascular Part II Symposium

Related

Open-Label Study Evaluating the Effects of the CCR3 Antagonist ALK4290 in Patients With Neovascular AMD Refractory to Anti-VEGF Therapy
Michael W. Stewart, MD
Annual Meeting Talks
2019
The Role of Wide-Field Fluorescien Angiography
Cynthia X Qian, MD
Updates from the Field
2017
96-Week Visual and Expanded Anatomical Outcomes of Brolucizumab Versus Aflibercept in Patients With nAMD: Results From HAWK and HARRIER
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more